Statutes, codes, and regulations
Code of Laws of South Carolina 1976
Title 40 - PROFESSIONS AND OCCUPATIONS
Chapter 43 - SOUTH CAROLINA PHARMACY PRACTICE ACT
Section 40-43-210 - Definitions

S.C. Code § 40-43-210

Download
PDF
Current through 2024 Act No. 225.
Section 40-43-210 - Definitions

As used in this chapter:

(1) "Administer" has the same meaning as in Section 40-43-30.
(2) "Department" means the Department of Labor, Licensing and Regulation.
(3) "Dispense" has the same meaning as in Section 40-43-30.
(4) "Injectable hormonal contraceptive" means a drug composed of a hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that a practitioner administers to a patient by injection. "Injectable hormonal contraceptive" does not include any drug intended to terminate a pregnancy.
(5) "Patient counseling" has the same meaning as in Section 40-43-30.
(6) "Pharmacist" has the same meaning as in Section 40-43-30.
(7) "Practitioner" has the same meaning as in Section 40-47-20.
(8) "Prescriber" means a physician licensed pursuant to Chapter 47, Title 40; an advanced practice registered nurse licensed pursuant to Chapter 33, Title 40 and prescribing in accordance with the requirements of that chapter; or a physician assistant licensed pursuant to Article 7, Chapter 47, Title 40 and prescribing in accordance with the requirements of that article.
(9) "Self-administered hormonal contraceptive" means a drug composed of a hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may administer to himself. "Self-administered hormonal contraceptive" includes an oral hormonal contraceptive, a hormonal vaginal ring, and a hormonal contraceptive patch. "Self-administered hormonal contraceptive" does not include any drug intended to terminate a pregnancy.

S.C. Code § 40-43-210

Added by 2022 S.C. Acts, Act No. 210 (SB 628),s 2, eff. 5/23/2022.

2022 Act No. 210, Sections 1, 4, and 6, provide as follows:

"SECTION 1. This act shall be referred to as the 'Pharmacy Access Act'."

"SECTION 4. The Board of Medical Examiners and the Board of Pharmacy must issue a written joint protocol pursuant to Section 40-43-240 not later than six months after the passage of this act."

"SECTION 6. Except as otherwise specifically provided, this act takes effect upon the issuance of a written joint protocol pursuant to SECTION 4 of this act."

The written joint protocol was issued on November 16, 2022.